Visitors Now:
Total Visits:
Total Stories:
Profile image
Story Views

Now:
Last Hour:
Last 24 Hours:
Total:

Global Next Generation Sequencing (NGS) Market 2016 Share, Trend, Segmentation and Forecast to 2020

Monday, November 7, 2016 1:25
% of readers think this story is Fact. Add your two cents.

(Before It's News)

The Global market for Next Generation Sequencing is poised to reach $10 billion by the end of 2020 growing at a CAGR of approximately 20%. The instruments and consumables is the largest segment with a share of around half of the market in 2013. The fastest growing segment is the services with a highest CAGR during the forecast period. The major players are interested in services segment as it provides additional revenue for the company at the same time, increases the sales of instruments and reagents. The major players operating in the NGS market are Illumina Inc (U.S.), Thermo Fisher Scientific (U.S.), Hoffmann-La Roche Ltd (Switzerland), Pacific Bioscieces (U.S.) Agilent Technologies (U.S.), BGI (Beijing Genomics Institute) (China), Qiagen (Netherlands), Biomatters Ltd (New Zealand), and Genomatix Software GmbH (Germany).

Request a sample report @ https://www.wiseguyreports.com/sample-request/364820-global-next-generation-sequencing-ngs-market-growth-trends-forecasts-2015-2020

Currently, North America is the largest market for NGS. This is due to the increased awareness about the quick return of investments and accuracy. Asia Pacific is the fastest growing segment. The Next Generation Sequencing market can be segmented on the basis of Technology (Whole Genome Sequencing, Targeted Resequencing, Whole Exome Sequencing, RNA Sequencing, Chip Sequencing, De Novo Sequencing and Methyl Sequencing), Products (Instruments, Reagents & Consumables, and Services), End user (Hospitals & Healthcare Institutions, Academics, Biotech & Pharma Firms, and Others), Applications (Drug Discovery, Genetic Screening, Diagnostics, Personalized Medicine, Agriculture And Animal Research, Infectious Diseases, and Others) and Geography (North America, Europe, APAC & RoW).

Drivers

Increasing applications in clinical diagnosis boosting the market growth, Speed, cost and accuracy to spur the market growth, Efficient replacement for traditional technologies (Microarrays), and Drug discovery applications demanding NGS technology are the major factors driving the growth of the market.

Restraints

Legal & ethical issues to hamper the market growth, Interpretation of complex data, and Lack of skilled professionals are the major restraints that are hampering the NGS market growth.

What the report offers

Market Definition for the specified topic along with identification of key drivers and restraints for the market. 
Market analysis for the Global Next Generation Sequencing Market, with region specific assessments and competition analysis on a global and regional scale. 
Identification of factors instrumental in changing the market scenarios, rising prospective opportunities and identification of key companies which can influence the market on a global and regional scale. 
Extensively researched competitive landscape section with profiles of major companies along with their strategic initiatives and market shares.� 
Identification and analysis of the Macro and Micro factors that affect the Global Next Generation Sequencing market on both global and regional scale. 
A comprehensive list of key market players along with the analysis of their current strategic interests and key financial information.

Complete report details @ https://www.wiseguyreports.com/reports/364820-global-next-generation-sequencing-ngs-market-growth-trends-forecasts-2015-2020       

Key points in table of content

INTRODUCTION 
Study Deliverables 
Market Definition 
Sizing Units 
Base Currency 
Review and forecast period years 
General Study Assumptions 
RESEARCH METHODOLOGY 
Introduction 
Analysis Methodology 
Econometric forecast models 
Research Assumptions 
EXECUTIVE SUMMARY 
KEY INFERENCES 
MARKET OVERVIEW AND INDUSTRY TRENDS 
Current market scenario 
Technology Overview 
New developments in therapeutics 
Investment analysis 
Porters Five Force Analysis 
Bargaining Power of suppliers 
Bargaining power of buyers 
Degree of competition 
Threat of substitution 
Threat of new entrants 
DRIVERS, RESTRAINTS, OPPORTUNITIES AND CHALLENGES ANALYSIS (DROC) 
Market Drivers 
Increasing applications in clinical diagnosis boosting the market growth 
Speed, cost and accuracy to spur the market growth 
Efficient replacement for traditional technologies (Microarrays) 
Drug discovery applications demanding NGS technology 
Market Restraints 
Legal & ethical issues to hamper the market growth 
Interpretation of complex data 
Lack of skilled professionals 
Market Opportunities 
In NGS Technology, Personalized Medicine & Biomarker 
Pre-Sequencing 
Cloud Computing 
Key Challenges 
Interpretation Of Complex Data From NGS Platforms 
Clinical Translation of Genomic Discoveries

GLOBAL NEXT GENERATION SEQUENCING (NGS) MARKET SEGMENTATION

By Technology 
Whole Genome Sequencing 
Targeted Resequencing 
Whole Exome Sequencing 
Rna Sequencing 
Chip Sequencing 
De Novo Sequencing 
Methyl Sequencing 
By Products 
Instruments 
Reagents & Consumables 
By End Users 
Services 
Hospitals & Healthcare Institutions 
Academics 
Biotech & Pharma Firms 
Others 
By Application 
Drug Discovery 
Genetic Screening 
Diagnostics 
Personalized Medicine 
Agriculture And Animal Research 
Infectious Diseases 
Others 

GLOBAL NEXT GENERATION SEQUENCING (NGS) MARKET SEGMENTATION BY GEOGRAPHY – REGIONAL SHARES AND FORECAST 
North America 
USA 
Canada 
Mexico 
Europe 
France 
UK 
Germany 
Spain and Portugal 
Scandinavia 
Italy 
BENELUX 
Asia-Pacific 
India 
China 
Japan 
South Korea 
Australia and New Zealand 
Rest of Asia Pacific 
Middle East and Africa 
GCC 
Egypt 
Morocco 
Algeria 
South Africa 
Rest of Middle East and Africa 
Latin America 
Brazil 
Argentina 
Rest of Latin America 
COMPETITIVE LANDSCAPE 
Merger and Acquisition Analysis 
Patent Analysis 
The Challengers 
KEY VENDORS 
Roche Holding Ag 
Agilent Technologies, Inc 
BGI (Beijing Genomics Institute) 
Biomatters, Ltd 
Qiagen 
Dnastar, Inc 
Gatc Biotech Ag 
Genomatix Software Gmbh 
Illumina, Inc 
Knome, Inc 
Thermo Fisher Scientific 
Macrogen, Inc 
Oxford Nanopore Technologies, Ltd 
Pacific Biosciences 
Partek Incorporated 
Perkin Elmer, Inc 
ANALYST OUTLOOK FOR INVESTMENT OPPORTUNITIES 
FUTURE OUTLOOK OF THE MARKET 

APPENDIX 
Abbreviations 
Bibliography 
Disclaimer

Get this report @ https://www.wiseguyreports.com/checkout?currency=one_user-USD&report_id=364820

Contact US:

NORAH TRENT

Partner Relations & Marketing Manager

sales@wiseguyreports.com

Ph: +1-646-845-9349 (US)

Ph: +44 208 133 9349 (UK)           

 

Report abuse

Comments

Your Comments
Question   Razz  Sad   Evil  Exclaim  Smile  Redface  Biggrin  Surprised  Eek   Confused   Cool  LOL   Mad   Twisted  Rolleyes   Wink  Idea  Arrow  Neutral  Cry   Mr. Green

Top Stories
Recent Stories

Register

Newsletter

Email this story
Email this story

If you really want to ban this commenter, please write down the reason:

If you really want to disable all recommended stories, click on OK button. After that, you will be redirect to your options page.